University of Wisconsin, Madison: Prostatic Neoplasms trials
The registry lists 33 Prostatic Neoplasms studies with University of Wisconsin, Madison as lead sponsor. 3 are open to participants now and 14 have results posted.
Early Phase 1 3Phase 1 8Phase 2 20Phase 3 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPCRecruitingNCT07090148Phase 1
- Using FAPI PET/MRI to Evaluate Prostate CancerRecruitingNCT06675357Phase 2
- PET/CT Characterization of Treatment ResistanceRecruitingNCT05647564Not applicable
- pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate CancerActive, not recruitingNCT04090528Phase 2Results posted
- Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed TherapyActive, not recruitingNCT03725761Phase 2Results posted
- pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate CancerActive, not recruitingNCT03600350Phase 2Results posted
- Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate CancerCompletedNCT02499835Phase 1/2Results posted
- NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone MetastasisTerminatedNCT01816048Phase 2Results posted
- Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate CancerCompletedNCT01706458Phase 2Results posted
- Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate CancerTerminatedNCT01533753Phase 2Results posted
- Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate CancerCompletedNCT01341652Phase 2Results posted
- ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate CancerTerminatedNCT01119118Phase 2Results posted
- Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate CancerCompletedNCT00849121Phase 2Results posted
- CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate CancerTerminatedNCT00702923Phase 1Results posted
- Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation TherapyCompletedNCT00582556Phase 2Results posted
- Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic NodesCompletedNCT00214136Phase 2Results posted
- Phase I/II Hypofractionated Radiotherapy for Prostate CancerCompletedNCT00214097Phase 1/2Results posted
- Imaging and Genomic Biomarkers to Predict Response in Prostate CancerActive, not recruitingNCT05477823Early Phase 1
- Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate CancerActive, not recruitingNCT04989946Phase 1/2
- Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate CancerCompletedNCT03358563Early Phase 1
- PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate CancerCompletedNCT03232164Early Phase 1
- Survivorship Care Plans in a Community Oncology PracticeCompletedNCT03028584
- Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPCCompletedNCT02677376
- A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSFCompletedNCT02411786Phase 1
- Effect of Cancer Nurse Navigators on Patient OutcomesTerminatedNCT01902823Phase 2/3
- Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed TherapyCompletedNCT01516866
- Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate CancerTerminatedNCT00585416Phase 2
- Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate CancerTerminatedNCT00582582Phase 2
- Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate CancerCompletedNCT00582140Phase 1
- CHESS Caregivers Study: Web-based Support for Informal Caregivers in CancerCompletedNCT00214162Not applicable
- Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
- Doxercalciferol Before Surgery in Treating Localized Prostate CancerCompletedNCT00022412Phase 2
- Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00003238Phase 2